NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites of inflammation. NanoGhost offers a novel, versatile, and highly selective targeted drug delivery platform for the treatment of oncological diseases. NanoGhosts can be loaded with various drug types, preserve MSCs tropism to cancer cells, and selectively penetrate tumors (including brain tumors while crossing the BBB and pancreatic cancer), leading to a major reduction in tumor size and prolonged survival.
| Website | https://www.nano-ghost.com/ |
| Employees | 10 (8 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Drug Delivery, Nanotechnology, Biotech, Stem Cell Therapy, Targeted Drug Delivery, Cancer Treatment, Inflammation Treatment, Mesenchymal Stem Cells, Pharmaceutical, Biotechnology, Regenerative Medicine, Precision Medicine, Drug Development, Therapeutic Platform, Nanomedicine, Innovative Therapies, Clinical Trials |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, 10x Genomics, Molecular Devices, NanoString Technologies, Inc. +42 more (view full list) |
Looking for a particular NanoGhost employee's phone or email?
NanoGhost Questions
Yonatan Malca is the CEO of NanoGhost.
8 people are employed at NanoGhost.
Top NanoGhost Employees
-
Yonatan Malca
Chief Executive Officer at NanoGhost
Tel Aviv District, Israel1 -
Maxim Mogilevsky
Project Leader at NanoGhost
Center District, Israel1 -
Michal Lulu
Analytical Method Development Project Leader at NanoGhost
Center District, Israel21 -
Ziv Azoulay
R and D Project Manager at NanoGhost
Tel Aviv-Yafo, IL1 -
Tamar Evron-Levy
MRNA project leader at NanoGhost
Hod Hasharon, IL1 -
1
Related Companies
